Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

被引:39
作者
Chandran, M. [1 ]
Mitchell, P. J. [2 ]
Amphansap, T. [3 ]
Bhadada, S. K. [4 ]
Chadha, M. [5 ]
Chan, D. -C. [6 ]
Chung, Y. -S. [7 ]
Ebeling, P. [8 ]
Gilchrist, N. [9 ]
Habib Khan, A. [10 ]
Halbout, P. [11 ]
Hew, F. L. [12 ]
Lan, H. -P. T. [13 ]
Lau, T. C. [14 ]
Lee, J. K. [15 ]
Lekamwasam, S. [16 ]
Lyubomirsky, G. [17 ]
Mercado-Asis, L. B. [18 ]
Mithal, A. [19 ]
Nguyen, T. V. [20 ]
Pandey, D. [21 ]
Reid, I. R. [22 ]
Suzuki, A. [23 ]
Chit, T. T. [24 ]
Tiu, K. L. [25 ]
Valleenukul, T. [26 ]
Yung, C. K. [27 ,28 ]
Zhao, Y. L. [29 ]
机构
[1] Singapore Gen Hosp, Dept Endocrinol, Osteoporosis & Bone Metab Unit, 20 Coll Rd, Singapore 169856, Singapore
[2] Synth Med NZ Ltd, Auckland, New Zealand
[3] Police Gen Hosp, Dept Orthoped, Bangkok, Thailand
[4] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh, India
[5] Hinduja Hosp & Res Ctr, Dept Endocrinol, Mumbai, Maharashtra, India
[6] Natl Univ Hosp, Internal Med, ChuT ung Branch, Chinese Taipei, Taiwan
[7] Ajou Univ, Dept Endocrinol & Metab, Sch Med, Suwon, South Korea
[8] Monash Hlth, Dept Med, Sch Clin Sci, Melbourne, Vic, Australia
[9] Canterbury Dist Hlth Board, Christchurch, New Zealand
[10] Aga Khan Univ, Sect Chem Pathol, Dept Pathol & Lab Med, Karachi, Pakistan
[11] Int Osteoporosis Fdn, Nyon, Switzerland
[12] Subang Jaya Med Ctr, Dept Med, Subang Jaya, Malaysia
[13] Ton Duc Thang Univ, Pham Ngoc Thach Univ Med, Bone & Muscle Res Grp, Musculoskeletal & Metab Unit,Biomed Res Ctr, Ho Chi Minh City, Vietnam
[14] Natl Univ Singapore Hosp, Div Rheumatol, Dept Med, Singapore, Singapore
[15] Beacon Int Specialist Ctr, Dept Orthoped, Petaling Jaya, Malaysia
[16] Univ Ruhuna, Fac Med, Galle, Sri Lanka
[17] Osteoporosis Australia, Sydney, NSW, Australia
[18] Univ Santo Tomas, Fac Med & Surg, Manila, Philippines
[19] Mithal M Max Healthcare Pan Max, Endocrinol, Diabet Div, Gurgaon, India
[20] Garvan Inst Med Reseach, Bone Biol Div, Genet & Epidemiol Osteoporosis Lab, Sydney, NSW, Australia
[21] Natl Trauma Ctr, Dept Orthopaed, Kathmandu, Nepal
[22] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand
[23] Fujita Hlth Univ, Sch Med, Dept Endocrinol, Toyoake, Aichi, Japan
[24] East Yangon Gen Hosp, Yangon, Myanmar
[25] Queen Elizabeth Hosp, Dept Orthopaed & Traumatol, Polytrauma & Fragil Fracture team, Hong Kong, Peoples R China
[26] Bhumibol Adulyadej Hosp, Dept Orthoped, Bangkok, Thailand
[27] Raja Isteri Pengiran Anak Saleha Hosp, Dept Endocrinol, Bandar Seri Begawan, Brunei
[28] Raja Isteri Pengiran Anak Saleha Hosp, Patient Safety Unit, Bandar Seri Begawan, Brunei
[29] Beijing United Family Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
关键词
Asia-Pacific; Consensus; Guidelines; Osteoporosis; Standards of care; COST-EFFECTIVENESS ANALYSIS; HIP FRACTURE; POSTMENOPAUSAL WOMEN; FRAGILITY FRACTURES; INCREASED RISK; INTERVENTION THRESHOLDS; SUBSEQUENT FRACTURE; IMMINENT RISK; AGED; 50; TERIPARATIDE;
D O I
10.1007/s00198-020-05742-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Guidelines for doctors managing osteoporosis in the Asia-Pacific region vary widely. We compared 18 guidelines for similarities and differences in five key areas. We then used a structured consensus process to develop clinical standards of care for the diagnosis and management of osteoporosis and for improving the quality of care. Purpose Minimum clinical standards for assessment and management of osteoporosis are needed in the Asia-Pacific (AP) region to inform clinical practice guidelines (CPGs) and to improve osteoporosis care. We present the framework of these clinical standards and describe its development. Methods We conducted a structured comparative analysis of existing CPGs in the AP region using a "5IQ" model (identification, investigation, information, intervention, integration, and quality). One-hundred data elements were extracted from each guideline. We then employed a four-round Delphi consensus process to structure the framework, identify key components of guidance, and develop clinical care standards. Results Eighteen guidelines were included. The 5IQ analysis demonstrated marked heterogeneity, notably in guidance on risk factors, the use of biochemical markers, self-care information for patients, indications for osteoporosis treatment, use of fracture risk assessment tools, and protocols for monitoring treatment. There was minimal guidance on long-term management plans or on strategies and systems for clinical quality improvement. Twenty-nine APCO members participated in the Delphi process, resulting in consensus on 16 clinical standards, with levels of attainment defined for those on identification and investigation of fragility fractures, vertebral fracture assessment, and inclusion of quality metrics in guidelines. Conclusion The 5IQ analysis confirmed previous anecdotal observations of marked heterogeneity of osteoporosis clinical guidelines in the AP region. The Framework provides practical, clear, and feasible recommendations for osteoporosis care and can be adapted for use in other such vastly diverse regions. Implementation of the standards is expected to significantly lessen the global burden of osteoporosis.
引用
收藏
页码:1249 / 1275
页数:27
相关论文
共 90 条
[1]   Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle [J].
Akesson, K. ;
Marsh, D. ;
Mitchell, P. J. ;
McLellan, A. R. ;
Stenmark, J. ;
Pierroz, D. D. ;
Kyer, C. ;
Cooper, C. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) :2135-2152
[2]   Usefulness of a national hip fracture registry to evaluate the profile of patients in whom antiosteoporotic treatment is prescribed following hospital discharge [J].
Alarcon, T. ;
Ojeda-Thies, C. ;
Saez-Lopez, P. ;
Gomez-Campelo, P. ;
Navarro-Castellanos, L. ;
Otero-Puime, A. ;
Gonzalez-Montalvo, J. I. .
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (07) :1369-1375
[3]   Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures [J].
Angthong, Chayanin ;
Rodjanawijitkul, Santi ;
Samart, Supawat ;
Angthong, Wirana .
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA, 2013, 47 (05) :318-322
[4]  
[Anonymous], Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age
[5]   Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry [J].
Arya, Ashutosh Kumar ;
Kumari, Poonam ;
Bhadada, Sanjay Kumar ;
Agrawal, Kanhaiya ;
Singh, Priyanka ;
Mukherjee, Soham ;
Sood, Ashwani ;
Rao, Sudhaker D. .
JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) :253-259
[6]  
Australian and New Zealand Bone and Mineral Society, 2016, SEC FRACT PREV PROGR
[7]  
Australian and New Zealand Hip Fracture Registry, AUSTR NZ HIP FRACT R
[8]   Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons [J].
Baba, T. ;
Hagino, H. ;
Nonomiya, H. ;
Ikuta, T. ;
Shoda, E. ;
Mogami, A. ;
Sawaguchi, T. ;
Kaneko, K. .
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (07) :1959-1963
[9]  
Babhulkar, 2020, CLIN PRACTICE GUIDEL
[10]   Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women [J].
Bliuc, Dana ;
Nguyen, D. Nguyen ;
Milch, Vivienne E. ;
Nguyen, Tuan V. ;
Eisman, John A. ;
Center, Jacqueline R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (05) :513-521